Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Filter by Categories
Biosimilars Deals 2023
Biosimilars Deals 2024
Chris Vindurampulle
Other Podcasts
Other Updates
Our Awards
Patent Case Summaries
Patent Litigation
Paul Johns
Trade Marks

Adalvo’s Liraglutide Pre-Filled Pen Obtains First Generic Approval in EuropeAdalvo’s Liraglutide Pre-Filled Pen Obtains First Generic Approval in Europe

Jun 13, 2024

On 13 June 2024, Adalvo announced its liraglutide pre-filled pen has been approved in the EU, making it the first EU approved generic liraglutide.  Originator Novo Nordisk supplies liraglutide as Victoza® in EU which is indicated for the treatment of type 2 diabetes. Adalvo received approval via the decentralised procedure. 

According to Adalvo’s announcement, Victoza achieved over $4.8 billion in global sales in 2023. 

This news follows Biocon’s 27 March 2024 announcement of its approval of synthetic liraglutide in the UK.